Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial

Overview of attention for article published in Arthritis & Rheumatology, July 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

bluesky: 1 Bluesky user

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 13,089 followers.

6⃣ posthoc analysis of STOP gout trial Barry et al https://t.co/hBrEi3KnRg No ⬆️ flare risk a/w dose escalation of allopurinol ⬆️ flare risk: higher baseline SU, younger age #2024GCAN #ACR24

RT @enriquecalvoA: 📑Riesgo de ataque similar al titular gradualmente ALO o FBX @Tuhina_Neogi @TonyMerriman2 @MikulsTed A Comparison of…

📑Riesgo de ataque similar al titular gradualmente ALO o FBX @Tuhina_Neogi @TonyMerriman2 @MikulsTed A Comparison of Gout Flares with the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐hoc Analysis of a Randomized Multicenter Trial …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.